![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Miller, Michael; Tokgozoglu, Lale; Parhofer, Klaus G.; Handelsman, Yehuda; Leiter, Lawrence A.; Landmesser, Ulf; Brinton, Eliot A. und Catapano, Alberico L.
(2022):
Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements.
In: Expert Review of Cardiovascular Therapy, Bd. 20, Nr. 8: S. 609-625
Evans, Paul C.; Davidson, Sean M.; Wojta, Johann; Baeck, Magnus; Bollini, Sveva; Brittan, Mairi; Catapano, Alberico L.; Chaudhry, Bill; Cluitmans, Matthijs; Gnecchi, Massimiliano; Guzik, Tomasz J.; Hoefer, Imo; Madonna, Rosalinda; Monteiro, Joao P.; Morawietz, Henning; Osto, Elena; Padro, Teresa; Sluimer, Judith C.; Tocchetti, Carlo Gabriele; Heiden, Kim van der; Vilahur, Gemma; Waltenberger, Johannes und Weber, Christian
(2022):
From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22.
In: Cardiovascular Research, Bd. 118, Nr. 13: S. 2754-2767
[PDF, 2MB]
Hegele, Robert A.; Boren, Jan; Ginsberg, Henry N.; Arca, Marcello; Averna, Maurizio; Binder, Christoph J.; Calabresi, Laura; Chapman, M. John; Cuchel, Marina; Eckardstein, Arnold von; Frikke-Schmidt, Ruth; Gaudet, Daniel; Hovingh, G. Kees; Kronenberg, Florian; Luetjohann, Dieter; Parhofer, Klaus G.; Raal, Frederick J.; Ray, Kausik K.; Remaley, Alan T.; Stock, Jane K.; Stroes, Erik S.; Tokgozoglu, Lale und Catapano, Alberico L.
(2020):
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement.
In: Lancet Diabetes & Endocrinology, Bd. 8, Nr. 1: S. 50-67
Hoogeveen, Renate M.; Nahrendorf, Matthias; Riksen, Niels P.; Netea, Mihai G.; Winther, Menno P. J. de; Lutgens, Esther; Nordestgaard, Borge G.; Neidhart, Michel; Stroes, Erik S. G.; Catapano, Alberico L. und Bekkering, Siroon
(2018):
Monocyte and haematopoietic progenitor reprogramming as commonmechanism underlying chronic inflammatory and cardiovascular diseases.
In: European Heart Journal, Bd. 39, Nr. 38: S. 3521-3527